Prediction of onset of crystallization from experimental relaxation times. II. Comparison between predicted and experimental onset times

被引:64
作者
Bhugra, Chandan [1 ,2 ]
Shmeis, Rama [2 ]
Krill, Steven L. [2 ]
Pikal, Michael J. [1 ]
机构
[1] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA
[2] Boehringer Ingelheim Pharmaceut Inc, Pharmaceut R&D, Ridgefield, CT 06877 USA
关键词
amorphous pharmaceuticals; molecular mobility; dielectric relaxation; calorimetry (TAM); physical stability; glass transition; crystallization prediction; induction time; relaxation time; growth rate;
D O I
10.1002/jps.21162
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Given a good correlation between onsets of crystallization and mobility above T-g, one might be able to predict crystallization onsets at a temperature of interest far below T-g, from this correlation and measurement of mobility at a temperature below T-g, Such predictions require that: (a) correlation between crystallization onset and mobility is the same above and below T-g, and (b) techniques used to measure mobility above and below T-g, measure the same kind of mobility [(b) demonstrated previously using dielectric and calorimetric techniques]. The objective of present work is to determine whether crystallization onset times couple with relaxation times determined above T-g, and if so to verify predictions made below T-g (from data above T-g) with experimental data. Model compounds were indomethacin, ketoconazole, flopropione, nifedipine, and felodipine. Onsets of crystallization measured above T-g were coupled with dielectric mobility for indomethacin, felodipine, and flopropione. Prediction of crystallization onset times for temperatures below T-g matched well with experimental data for indomethacin (25 degrees C, 35 degrees C: Predicted 473, 95 h; Experimental: 624 +/- 158, 139 +/- 49 h) and flopropione (35 degrees C, 40 degrees C; Predicted 115, 5 h; Experimental: 96 +/- 30, 59 +/- 10 h). The data suggests that coupling between crystallization onsets and molecular mobility at temperatures above Tg may be exploited to develop stability testing protocol for crystallization from amorphous state. (C) 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 97:455-472, 2008.
引用
收藏
页码:455 / 472
页数:18
相关论文
共 24 条
[1]   Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance [J].
Alie, J ;
Menegotto, J ;
Cardon, P ;
Duplaa, H ;
Caron, A ;
Lacabanne, C ;
Bauer, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (01) :218-233
[2]   Molecular mobility of supercooled amorphous indomethacin, determined by dynamic mechanical analysis [J].
Andronis, V ;
Zografi, G .
PHARMACEUTICAL RESEARCH, 1997, 14 (04) :410-414
[3]   Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMR [J].
Apperley, DC ;
Forster, AH ;
Fournier, R ;
Harris, RK ;
Hodgkinson, P ;
Lancaster, RW ;
Rades, T .
MAGNETIC RESONANCE IN CHEMISTRY, 2005, 43 (11) :881-892
[4]  
Aso Y, 2000, J PHARM SCI, V89, P408, DOI 10.1002/(SICI)1520-6017(200003)89:3<408::AID-JPS11>3.0.CO
[5]  
2-#
[6]   Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions [J].
Aso, Y ;
Yoshioka, S ;
Kojima, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (02) :384-391
[7]  
BHUGRA C, 2007, UNPUB J PHARM SCI
[8]  
BHUGRA C, 2007, UNPUB ROLE MECH STRE
[9]  
BHUGRA C, 2007, IN PRESS J PHARM SCI
[10]   Prediction of the onset of crystallization of amorphous sucrose below the calorimetric glass transition temperature from correlations with mobility [J].
Bhugra, Chandan ;
Rambhatla, Shailaja ;
Bakri, Aziz ;
Duddu, Sarma P. ;
Miller, Danforth P. ;
Pikal, Michael J. ;
Lechuga-Ballesteros, David .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (05) :1258-1269